STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicin-resistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxifloxacin and clofazimine, known to cause QT prolongation, and severe prolongation was more common on the Short regimen. This study investigated risk factors for QT prolongation with the Short regimen.
Recent Abstracts
Cost-Benefit Analysis for Air Pollution Control Strategies in Jakarta
Key Messages on Alcohol Harms and Policy Solutions
Flooding and Early Childhood Development
RESET Alcohol – Public Attitudes Towards Alcohol Policy in Mexico
Accelerating the Health Benefits of Scaling Clean Household Energy in India
Childhood Blood Lead Surveillance in Bihar
Preventing Childhood Lead Exposure: Assessing the Comprehensive Approach Capacity in Peru
RESET Alcohol – Public opinion, attitudes and support for government action on alcohol…
RESET Alcohol – Public opinion, attitudes and support for government action on alcohol…
Childhood Lead Exposure Prevention: Assessment of Blood Lead Surveillance Capacity in Colombia